Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lexaria Bioscience (LEXX) Cost of Revenue (2017 - 2024)

Lexaria Bioscience's Cost of Revenue history spans 8 years, with the latest figure at $2720.0 for Q4 2024.

  • Quarterly results put Cost of Revenue at $2720.0 for Q4 2024, down 43.59% from a year ago — trailing twelve months through Aug 2025 was $2720.0 (down 43.59% YoY), and the annual figure for FY2025 was $2720.0, down 43.59%.
  • Cost of Revenue for Q4 2024 was $2720.0 at Lexaria Bioscience, down from $4822.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $64478.0 in Q4 2020 to a low of $2720.0 in Q4 2024.
  • The 5-year median for Cost of Revenue is $17215.0 (2022), against an average of $23609.6.
  • The sharpest move saw Cost of Revenue surged 2060.07% in 2020, then tumbled 91.36% in 2021.
  • Year by year, Cost of Revenue stood at $64478.0 in 2020, then tumbled by 91.36% to $5570.0 in 2021, then skyrocketed by 183.57% to $15795.0 in 2022, then plummeted by 69.47% to $4822.0 in 2023, then plummeted by 43.59% to $2720.0 in 2024.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $2720.0, $4822.0, and $12747.0 for Q4 2024, Q4 2023, and Q2 2023 respectively.